{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>title</th>\n",
       "      <th>authors</th>\n",
       "      <th>countries</th>\n",
       "      <th>abstract</th>\n",
       "      <th>publication_date</th>\n",
       "      <th>doi</th>\n",
       "      <th>author_disclosures</th>\n",
       "      <th>product_name</th>\n",
       "      <th>company_name</th>\n",
       "      <th>company_in_the_list</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Adjuvant Nivolumab in High-Risk Muscle-Invasiv...</td>\n",
       "      <td>Matthew D.  Galsky; Johannes Alfred  Witjes; J...</td>\n",
       "      <td>NY; the Netherlands; Germany; NC; Romania; Spa...</td>\n",
       "      <td>Clinical trials frequently include multiple en...</td>\n",
       "      <td>1/1/2025</td>\n",
       "      <td>JCO.24.00340</td>\n",
       "      <td>[{'Author': 'Matthew D. Galsky', 'Disclosures'...</td>\n",
       "      <td>nivolumab</td>\n",
       "      <td>Bristol Myers Squibb</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Impact of an Epstein-Barr Virus Serology-Based...</td>\n",
       "      <td>Wen-Jie  Chen; Xia  Yu; Yu-Qiang  Lu; Ruth M. ...</td>\n",
       "      <td>China; China; China; China; MD; China; China; ...</td>\n",
       "      <td>Purpose: Screening for nasopharyngeal carcinom...</td>\n",
       "      <td>1/1/2025</td>\n",
       "      <td>JCO.23.01296</td>\n",
       "      <td>[{'Author': 'Zhiwei Liu', 'Disclosures': ['Emp...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Single or Double Induction With 7 + 3 Containi...</td>\n",
       "      <td>Christoph  RÃ¶llig; BjÃ¶rn  Steffen; Christoph...</td>\n",
       "      <td>Germany; Germany; Germany; Germany; Germany; G...</td>\n",
       "      <td>Purpose: To determine the optimal daunorubicin...</td>\n",
       "      <td>1/1/2025</td>\n",
       "      <td>JCO.24.00235</td>\n",
       "      <td>[{'Author': 'Christoph RÃ¶llig', 'Disclosures'...</td>\n",
       "      <td>daunorubicin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Menin Inhibition With Revumenib for KMT2A-Rear...</td>\n",
       "      <td>Ghayas C.  Issa; Ibrahim  Aldoss; Michael J.  ...</td>\n",
       "      <td>TX; CA; IL; MO; GA; OH; CA; PA; IA; CO; OR; th...</td>\n",
       "      <td>Purpose: Revumenib, an oral, small molecule in...</td>\n",
       "      <td>1/1/2025</td>\n",
       "      <td>JCO.24.00826</td>\n",
       "      <td>[{'Author': 'Ghayas C. Issa', 'Disclosures': [...</td>\n",
       "      <td>revumenib</td>\n",
       "      <td>Syndax</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Inotuzumab Ozogamicin and Low-Intensity Chemot...</td>\n",
       "      <td>Patrice  Chevallier; Thibaut  Leguay; Marc  De...</td>\n",
       "      <td>France; France; France; United Kingdom; Czech ...</td>\n",
       "      <td>Purpose: The use of inotuzumab ozogamicin (InO...</td>\n",
       "      <td>12/20/2024</td>\n",
       "      <td>JCO.24.00490</td>\n",
       "      <td>[{'Author': 'Patrice Chevallier', 'Disclosures...</td>\n",
       "      <td>inotuzumab ozogamicin</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                               title  \\\n",
       "0  Adjuvant Nivolumab in High-Risk Muscle-Invasiv...   \n",
       "1  Impact of an Epstein-Barr Virus Serology-Based...   \n",
       "2  Single or Double Induction With 7 + 3 Containi...   \n",
       "3  Menin Inhibition With Revumenib for KMT2A-Rear...   \n",
       "4  Inotuzumab Ozogamicin and Low-Intensity Chemot...   \n",
       "\n",
       "                                             authors  \\\n",
       "0  Matthew D.  Galsky; Johannes Alfred  Witjes; J...   \n",
       "1  Wen-Jie  Chen; Xia  Yu; Yu-Qiang  Lu; Ruth M. ...   \n",
       "2  Christoph  RÃ¶llig; BjÃ¶rn  Steffen; Christoph...   \n",
       "3  Ghayas C.  Issa; Ibrahim  Aldoss; Michael J.  ...   \n",
       "4  Patrice  Chevallier; Thibaut  Leguay; Marc  De...   \n",
       "\n",
       "                                           countries  \\\n",
       "0  NY; the Netherlands; Germany; NC; Romania; Spa...   \n",
       "1  China; China; China; China; MD; China; China; ...   \n",
       "2  Germany; Germany; Germany; Germany; Germany; G...   \n",
       "3  TX; CA; IL; MO; GA; OH; CA; PA; IA; CO; OR; th...   \n",
       "4  France; France; France; United Kingdom; Czech ...   \n",
       "\n",
       "                                            abstract publication_date  \\\n",
       "0  Clinical trials frequently include multiple en...         1/1/2025   \n",
       "1  Purpose: Screening for nasopharyngeal carcinom...         1/1/2025   \n",
       "2  Purpose: To determine the optimal daunorubicin...         1/1/2025   \n",
       "3  Purpose: Revumenib, an oral, small molecule in...         1/1/2025   \n",
       "4  Purpose: The use of inotuzumab ozogamicin (InO...       12/20/2024   \n",
       "\n",
       "            doi                                 author_disclosures  \\\n",
       "0  JCO.24.00340  [{'Author': 'Matthew D. Galsky', 'Disclosures'...   \n",
       "1  JCO.23.01296  [{'Author': 'Zhiwei Liu', 'Disclosures': ['Emp...   \n",
       "2  JCO.24.00235  [{'Author': 'Christoph RÃ¶llig', 'Disclosures'...   \n",
       "3  JCO.24.00826  [{'Author': 'Ghayas C. Issa', 'Disclosures': [...   \n",
       "4  JCO.24.00490  [{'Author': 'Patrice Chevallier', 'Disclosures...   \n",
       "\n",
       "            product_name          company_name  company_in_the_list  \n",
       "0              nivolumab  Bristol Myers Squibb                 True  \n",
       "1                    NaN                   NaN                False  \n",
       "2           daunorubicin                   NaN                False  \n",
       "3              revumenib                Syndax                 True  \n",
       "4  inotuzumab ozogamicin                Pfizer                 True  "
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "\n",
    "df = pd.read_csv('results/asco_articles_with_company_human_edited.csv')\n",
    "\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>title</th>\n",
       "      <th>authors</th>\n",
       "      <th>countries</th>\n",
       "      <th>abstract</th>\n",
       "      <th>publication_date</th>\n",
       "      <th>doi</th>\n",
       "      <th>author_disclosures</th>\n",
       "      <th>product_name</th>\n",
       "      <th>company_name</th>\n",
       "      <th>company_in_the_list</th>\n",
       "      <th>multiple_nationality</th>\n",
       "      <th>key_country</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Adjuvant Nivolumab in High-Risk Muscle-Invasiv...</td>\n",
       "      <td>Matthew D.  Galsky; Johannes Alfred  Witjes; J...</td>\n",
       "      <td>USA; the Netherlands; Germany; USA; Romania; S...</td>\n",
       "      <td>Clinical trials frequently include multiple en...</td>\n",
       "      <td>1/1/2025</td>\n",
       "      <td>JCO.24.00340</td>\n",
       "      <td>[{'Author': 'Matthew D. Galsky', 'Disclosures'...</td>\n",
       "      <td>nivolumab</td>\n",
       "      <td>Bristol Myers Squibb</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>USA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Impact of an Epstein-Barr Virus Serology-Based...</td>\n",
       "      <td>Wen-Jie  Chen; Xia  Yu; Yu-Qiang  Lu; Ruth M. ...</td>\n",
       "      <td>China; China; China; China; USA; China; China;...</td>\n",
       "      <td>Purpose: Screening for nasopharyngeal carcinom...</td>\n",
       "      <td>1/1/2025</td>\n",
       "      <td>JCO.23.01296</td>\n",
       "      <td>[{'Author': 'Zhiwei Liu', 'Disclosures': ['Emp...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>1</td>\n",
       "      <td>China</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Single or Double Induction With 7 + 3 Containi...</td>\n",
       "      <td>Christoph  RÃ¶llig; BjÃ¶rn  Steffen; Christoph...</td>\n",
       "      <td>Germany; Germany; Germany; Germany; Germany; G...</td>\n",
       "      <td>Purpose: To determine the optimal daunorubicin...</td>\n",
       "      <td>1/1/2025</td>\n",
       "      <td>JCO.24.00235</td>\n",
       "      <td>[{'Author': 'Christoph RÃ¶llig', 'Disclosures'...</td>\n",
       "      <td>daunorubicin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>0</td>\n",
       "      <td>Germany</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Menin Inhibition With Revumenib for KMT2A-Rear...</td>\n",
       "      <td>Ghayas C.  Issa; Ibrahim  Aldoss; Michael J.  ...</td>\n",
       "      <td>USA; USA; USA; USA; USA; USA; USA; USA; USA; U...</td>\n",
       "      <td>Purpose: Revumenib, an oral, small molecule in...</td>\n",
       "      <td>1/1/2025</td>\n",
       "      <td>JCO.24.00826</td>\n",
       "      <td>[{'Author': 'Ghayas C. Issa', 'Disclosures': [...</td>\n",
       "      <td>revumenib</td>\n",
       "      <td>Syndax</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>USA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Inotuzumab Ozogamicin and Low-Intensity Chemot...</td>\n",
       "      <td>Patrice  Chevallier; Thibaut  Leguay; Marc  De...</td>\n",
       "      <td>France; France; France; United Kingdom; Czech ...</td>\n",
       "      <td>Purpose: The use of inotuzumab ozogamicin (InO...</td>\n",
       "      <td>12/20/2024</td>\n",
       "      <td>JCO.24.00490</td>\n",
       "      <td>[{'Author': 'Patrice Chevallier', 'Disclosures...</td>\n",
       "      <td>inotuzumab ozogamicin</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "      <td>France</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                               title  \\\n",
       "0  Adjuvant Nivolumab in High-Risk Muscle-Invasiv...   \n",
       "1  Impact of an Epstein-Barr Virus Serology-Based...   \n",
       "2  Single or Double Induction With 7 + 3 Containi...   \n",
       "3  Menin Inhibition With Revumenib for KMT2A-Rear...   \n",
       "4  Inotuzumab Ozogamicin and Low-Intensity Chemot...   \n",
       "\n",
       "                                             authors  \\\n",
       "0  Matthew D.  Galsky; Johannes Alfred  Witjes; J...   \n",
       "1  Wen-Jie  Chen; Xia  Yu; Yu-Qiang  Lu; Ruth M. ...   \n",
       "2  Christoph  RÃ¶llig; BjÃ¶rn  Steffen; Christoph...   \n",
       "3  Ghayas C.  Issa; Ibrahim  Aldoss; Michael J.  ...   \n",
       "4  Patrice  Chevallier; Thibaut  Leguay; Marc  De...   \n",
       "\n",
       "                                           countries  \\\n",
       "0  USA; the Netherlands; Germany; USA; Romania; S...   \n",
       "1  China; China; China; China; USA; China; China;...   \n",
       "2  Germany; Germany; Germany; Germany; Germany; G...   \n",
       "3  USA; USA; USA; USA; USA; USA; USA; USA; USA; U...   \n",
       "4  France; France; France; United Kingdom; Czech ...   \n",
       "\n",
       "                                            abstract publication_date  \\\n",
       "0  Clinical trials frequently include multiple en...         1/1/2025   \n",
       "1  Purpose: Screening for nasopharyngeal carcinom...         1/1/2025   \n",
       "2  Purpose: To determine the optimal daunorubicin...         1/1/2025   \n",
       "3  Purpose: Revumenib, an oral, small molecule in...         1/1/2025   \n",
       "4  Purpose: The use of inotuzumab ozogamicin (InO...       12/20/2024   \n",
       "\n",
       "            doi                                 author_disclosures  \\\n",
       "0  JCO.24.00340  [{'Author': 'Matthew D. Galsky', 'Disclosures'...   \n",
       "1  JCO.23.01296  [{'Author': 'Zhiwei Liu', 'Disclosures': ['Emp...   \n",
       "2  JCO.24.00235  [{'Author': 'Christoph RÃ¶llig', 'Disclosures'...   \n",
       "3  JCO.24.00826  [{'Author': 'Ghayas C. Issa', 'Disclosures': [...   \n",
       "4  JCO.24.00490  [{'Author': 'Patrice Chevallier', 'Disclosures...   \n",
       "\n",
       "            product_name          company_name  company_in_the_list  \\\n",
       "0              nivolumab  Bristol Myers Squibb                 True   \n",
       "1                    NaN                   NaN                False   \n",
       "2           daunorubicin                   NaN                False   \n",
       "3              revumenib                Syndax                 True   \n",
       "4  inotuzumab ozogamicin                Pfizer                 True   \n",
       "\n",
       "   multiple_nationality key_country  \n",
       "0                     1         USA  \n",
       "1                     1       China  \n",
       "2                     0     Germany  \n",
       "3                     1         USA  \n",
       "4                     1      France  "
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# for countries column, if there are two capital letters, repalce it with USA\n",
    "df['countries'] = df['countries'].apply(lambda x: '; '.join(['USA' if isinstance(part.strip(), str) and len(part.strip()) == 2 and part.strip().isupper() else part.strip() \n",
    "                                                            for part in str(x).split(';')]) if isinstance(x, str) else x)\n",
    "\n",
    "# new column named \"multiple_nationality\" if country >=3, and main_country with the most frequent country\n",
    "df['multiple_nationality'] = df['countries'].apply(lambda x: 1 if len(set(country.strip() for country in str(x).split(';'))) > 2 else 0)\n",
    "df['main_country'] = df['countries'].apply(lambda x: max(\n",
    "    [country.strip() for country in str(x).split(';')], \n",
    "    key=lambda k: str(x).split(';').count(k.strip())\n",
    ") if isinstance(x, str) else x)\n",
    "\n",
    "df.head()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "asco_crawler",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.11"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
